STOCK TITAN

C21 Investments Provides MCTO Status Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF), a vertically integrated cannabis company, has provided a default status report regarding its Management Cease Trade Order (MCTO). The company filed its Annual Filings for the year ended January 31, 2024, on July 22, 2024, after receiving an MCTO from the British Columbia Securities Commission on May 31, 2024. However, C21 announced a delay in filing its Annual Stub Filings for the 2-month period ended March 31, 2024, which were due by July 29, 2024. The company expects to complete and file these documents by August 5, 2024. C21 confirms compliance with alternative information guidelines and will continue to issue bi-weekly default status reports until the Annual Stub Filings are completed.

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF), una compagnia di cannabis integrata verticalmente, ha fornito un rapporto sullo stato di default riguardante il suo Ordine di Sospensione della Gestione (MCTO). L'azienda ha presentato i suoi documenti annuali per l'anno chiuso il 31 gennaio 2024, il 22 luglio 2024, dopo aver ricevuto un MCTO dalla British Columbia Securities Commission il 31 maggio 2024. Tuttavia, C21 ha annunciato un ritardo nella presentazione dei suoi documenti annuali di anteprima per il periodo di 2 mesi fino al 31 marzo 2024, che dovevano essere presentati entro il 29 luglio 2024. L'azienda prevede di completare e presentare questi documenti entro il 5 agosto 2024. C21 conferma la conformità con le linee guida alternative per le informazioni e continuerà a emettere rapporti sullo stato di default ogni due settimane fino al completamento dei documenti annuali di anteprima.

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF), una compañía de cannabis integrada verticalmente, ha proporcionado un informe sobre el estado de incumplimiento en relación a su Orden de Suspensión de Gestión (MCTO). La empresa presentó sus Declaraciones Anuales para el año que finalizó el 31 de enero de 2024, el 22 de julio de 2024, después de recibir un MCTO de la Comisión de Valores de Columbia Británica el 31 de mayo de 2024. Sin embargo, C21 anunció un retraso en la presentación de sus Declaraciones Anuales Provisionales para el período de 2 meses que finalizó el 31 de marzo de 2024, que debían presentarse antes del 29 de julio de 2024. La compañía espera completar y presentar estos documentos antes del 5 de agosto de 2024. C21 confirma el cumplimiento con las pautas alternativas de información y continuará emitiendo informes de estado de incumplimiento quincenalmente hasta que se completen las Declaraciones Anuales Provisionales.

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF)는 수직적으로 통합된 대마초 회사로, 경영 중단 명령(MCTO)에 대한 기본 상태 보고서를 제공하였습니다. 회사는 2024년 1월 31일 종료 연도의 연례 제출서를 2024년 7월 22일에 제출했으며, 이는 2024년 5월 31일에 브리티시컬럼비아 증권위원회로부터 MCTO를 받은 후 이루어진 것입니다. 그러나 C21은 2024년 3월 31일 종료된 2개월 기간에 대한 연례 가칭 제출서 제출이 지연되었음을 발표했으며, 이 제출서는 2024년 7월 29일까지 완료되어야 합니다. 회사는 2024년 8월 5일까지 이 문서를 완성하여 제출할 계획입니다. C21은 대체 정보 지침 준수를 확인하며 연례 가칭 제출서가 완료될 때까지 격주 기본 상태 보고서를 계속 발행할 것입니다.

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF), une entreprise de cannabis intégrée verticalement, a fourni un rapport sur l'état de défaut concernant son Ordre d'Arrêt de Gestion (MCTO). La société a déposé ses Déclarations Annuelles pour l'année se terminant le 31 janvier 2024, le 22 juillet 2024, après avoir reçu un MCTO de la Commission des Valeurs Mobilères de la Colombie-Britannique le 31 mai 2024. Cependant, C21 a annoncé un retard dans la soumission de ses Déclarations Annuelles Provisoires pour la période de 2 mois se terminant le 31 mars 2024, qui devaient être soumises d'ici le 29 juillet 2024. L'entreprise prévoit de finaliser et de soumettre ces documents d'ici le 5 août 2024. C21 confirme sa conformité avec les directives alternatives d'information et continuera à émettre des rapports sur l'état de défaut toutes les deux semaines jusqu'à ce que les Déclarations Annuelles Provisoires soient complètes.

C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF), ein vertikal integriertes Cannabis-Unternehmen, hat einen Bericht über den Status des Defaults bezüglich seiner Management Cease Trade Order (MCTO) veröffentlicht. Das Unternehmen hat seine Jahresunterlagen für das am 31. Januar 2024 endende Jahr am 22. Juli 2024 eingereicht, nachdem es am 31. Mai 2024 eine MCTO von der British Columbia Securities Commission erhalten hatte. C21 gab jedoch eine Verzögerung bei der Einreichung seiner Jahrestatements für den 2-monatigen Zeitraum, der am 31. März 2024 endete, bekannt, die bis zum 29. Juli 2024 fällig waren. Das Unternehmen plant, diese Dokumente bis zum 5. August 2024 fertigzustellen und einzureichen. C21 bestätigt die Einhaltung der alternativen Informationsrichtlinien und wird weiterhin alle zwei Wochen Statusberichte über das Default ausgeben, bis die Jahrestatements abgeschlossen sind.

Positive
  • Annual Filings for the year ended January 31, 2024, were completed and filed on July 22, 2024
  • Company expects to file Annual Stub Filings by August 5, 2024
Negative
  • Delay in filing Annual Stub Filings beyond the July 29, 2024 deadline
  • Management Cease Trade Order (MCTO) prohibits company management from trading securities

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2024) - C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) ("C21" or the "Company"), a vertically integrated cannabis company, is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 - Management Cease Trade Orders ("NP 12-203").

As previously announced on May 31, 2024 (the "Announcement"), the Company applied for a management cease trade order ("MCTO") from the British Columbia Securities Commission (the "BCSC") due to an expected delay in filing of the audited consolidated financial statements for the year ended January 31, 2024 (the "Annual Financial Statements"), annual management's discussion and analysis for the same period and management certifications of annual filings (collectively, the "Annual Filings") beyond the deadline of May 31, 2024 prescribed by Canadian securities laws. The MCTO was granted by the BCSC on May 31, 2024. The MCTO prohibits the Company's management from trading in the securities of the Company until such time as the Annual Filings are filed. The MCTO does not affect the ability of any other shareholders of the Company to trade securities of the Company. The Company filed the Annual Filings on SEDAR+ (www.sedarplus.ca) on July 22, 2024.

As previously announced on July 22, 2023, as a result of the delay in filing the Annual Filings, the Company disclosed that the filing of its audited consolidated financial statements for the 2-month stub period ended March 31, 2024, its annual management's discussion and analysis for the same period and management certifications of annual filings (collectively, the "Annual Stub Filings"), which are required in connection with the Company's recent change of its financial year end from January 31 to March 31, will be delayed beyond the deadline of July 29, 2024 prescribed by Canadian securities laws. C21 and its auditors continue to work diligently and expeditiously towards completing the Annual Stub Filings, which is expected to occur on or before August 5, 2024. Upon completion of the auditors' internal review process, the Annual Stub Filings will be filed on SEDAR+ (www.sedarplus.ca).

The Company confirms that since the date of the Announcement: (i) there has been no material change to the information set out in the Announcement that has not been generally disclosed; (ii) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the "alternative information guidelines" under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Annual Stub Filings is continuing, each of which will be issued in the form of a news release; (iii) there has not been any other specified default by the Company under NP 12-203; (iv) the Company is not subject to any insolvency proceedings; and (v) there is no material information concerning the affairs of the Company that has not been generally disclosed.

For further inquiries, please contact:

Investor contact: 

Investor Relations
info@cxxi.ca
+1 833 289-2994

Company contact:
Michael Kidd
Chief Financial Officer and Director
Michael.Kidd@cxxi.ca

About C21 Investments Inc.

C21 Investments Inc. is a vertically integrated cannabis company that cultivates, processes, and distributes quality cannabis and hemp-derived consumer products in the United States. The Company is focused on value creation through the disciplined acquisition and integration of core retail, manufacturing, and distribution assets in strategic markets, leveraging industry-leading retail revenues with high-growth potential multi-market branded consumer packaged goods. The Company owns Silver State Relief and Silver State Cultivation in Nevada, including legacy Oregon brands Phantom Farms, Hood Oil and Eco Firma Farms. These brands produce and distribute a broad range of THC and CBD products from cannabis flowers, pre-rolls, cannabis oil, vaporizer cartridges and edibles. Based in Vancouver, Canada, additional information on C21 can be found at www.sedarplus.ca and www.cxxi.ca.

Cautionary Note Regarding Forward-Looking Information and Statements:

This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation and may constitute "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995 (collectively, "Forward-Looking Statements"). Forward-Looking Statements in this news release include, but are not limited to: the Company satisfying the information guidelines set out in NP 12-203 and the filing of the Annual Stub Filings on or before August 5, 2024 upon completion of the auditors' internal review process. Such Forward-Looking Statements represent the Company's beliefs and expectations regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.

Forward-Looking Statements are based on assumptions, estimates, analyses and opinions of management of the Company at the time they were provided or made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, including: (i) the expected filing of the Annual Stub Filings; (ii) the Company's continued ability to satisfy the information guidelines set out in NP 12-203; (iii) the duration of the MCTO; (iv) achieving the anticipated results of the Company's strategic plans; and (v) general economic, financial market, regulatory and political conditions in which the Company operates.

A variety of factors, including known and unknown risks, many of which are beyond the Company's control, could cause actual results to differ materially from the Forward-Looking Statements in this news release. Such factors include, without limitation: risks and uncertainties arising from any delay in filing the Annual Stub Filings; the Company's ability to satisfy the requirements of NP 12-203; the revocation of the MCTO and replacement with a cease trade order; the inability to effectively manage growth; inputs, suppliers and skilled labour being unavailable or available only at uneconomic costs; the adequacy of the Company's capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute the Company's business plan (either within the expected timeframe or at all); changes in general economic, business and political conditions, including changes in the financial markets; changes in applicable laws generally and adverse future legislative and regulatory developments involving medical and recreational marijuana; the risks of operating in the marijuana industry in the United States, and those other risk factors discussed in the Company's 20F filing with the U.S. Securities and Exchange Commission and Annual Information Form filing on SEDAR+.

Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the Forward-Looking Statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such Forward-Looking Statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Should assumptions underlying the Forward-Looking Statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The Forward-Looking Statements contained in this news release are made as of the date of this news release, and the Company does not undertake to update any Forward-Looking Statements that are contained or referenced herein, except in accordance with applicable securities laws.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/218502

FAQ

When did C21 Investments (CXXIF) file its Annual Filings for the year ended January 31, 2024?

C21 Investments filed its Annual Filings for the year ended January 31, 2024, on July 22, 2024.

What is the expected date for C21 Investments (CXXIF) to file its Annual Stub Filings?

C21 Investments expects to file its Annual Stub Filings on or before August 5, 2024.

Why was a Management Cease Trade Order (MCTO) issued for C21 Investments (CXXIF)?

An MCTO was issued due to an expected delay in filing the Annual Filings for the year ended January 31, 2024, beyond the May 31, 2024 deadline.

What period do the delayed Annual Stub Filings cover for C21 Investments (CXXIF)?

The delayed Annual Stub Filings cover the 2-month stub period ended March 31, 2024, following the company's change in financial year-end from January 31 to March 31.

C21 INVESTMENTS INC ORD

OTC:CXXIF

CXXIF Rankings

CXXIF Latest News

CXXIF Stock Data

25.81M
105.55M
12.07%
7.96%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver